FDA Wants Your Comments on CBD

FDA wants your comments on CBD…

and 16 other substances.

“Cannabidiol (CBD) is one of the active cannabinoids identified in cannabis. CBD has been shown to be beneficial in experimental models of several neurological disorders, including those of seizure and epilepsy.”

These comments will be considered in preparing a response from the United States to the World Health Organization (WHO) regarding the abuse liability and diversion of these drugs. Comments must be submitted by September 17, 2017.

Click here for more information and to submit your comments.


This entry was posted in Blog and tagged , .

Leave a Reply

Your email address will not be published. Required fields are marked *